CiVi Biopharma ApS: Financial statements 2020
CVR: 38027794
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
CiVi Biopharma ApS (CVR 38027794) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 4,484,621 and a net result of DKK 391,972 compared with DKK 648,729 the year before. That is a decrease of 38% compared with the year before. Equity in the 2020 report amounted to DKK 2,705,031. The solvency ratio was 65.7%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 4,484,621
- Profit/Loss
- DKK 391,972
- Equity
- DKK 2,705,031
- Total Assets
- DKK 4,114,307
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 4.5M | 392K | 2.7M | 1 |
| 2019 | - | 7.2M | 649K | 2.3M | 1 |
| 2018 | - | 6M | 707K | 1.7M | 1 |
Official annual report
How creditworthy is CiVi Biopharma ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
CiVi Biopharma ApS has published its annual report for 2019. Gross profit came to DKK 7,236,687, and the net result was DKK 648,729.
About CiVi Biopharma ApS
CiVi Biopharma ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2016. The company has been dissolved on 5 February 2026. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named CiVi Biopharma A/S. The company has 1 employee (2024). In 2024, the company reported a gross profit of DKK 610,531 and a net result of DKK -1,410,204 compared with DKK -1,887,334 the year before. Equity in the 2024 report amounted to DKK 77,815.